|
Volumn 2, Issue 9, 2001, Pages 789-792
|
The risk of autoimmunity associated with tumor immunotherapy
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIGEN;
CANCER VACCINE;
CELL ANTIGEN;
GENE PRODUCT;
TUMOR ANTIGEN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN EXPRESSION;
ANTIGEN SPECIFICITY;
AUTOIMMUNITY;
CANCER IMMUNOTHERAPY;
CONTROLLED STUDY;
DRUG TARGETING;
HUMAN;
IMMUNOPATHOLOGY;
MOUSE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TUMOR REGRESSION;
ANTIGENS, NEOPLASM;
AUTOANTIGENS;
AUTOIMMUNE DISEASES;
AUTOIMMUNITY;
CANCER VACCINES;
HUMANS;
NEOPLASMS;
SELF TOLERANCE;
T-LYMPHOCYTES;
|
EID: 0035554675
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni0901-789 Document Type: Note |
Times cited : (81)
|
References (34)
|